
Medical device maker Becton Dickinson's BDX.N shares gain 5.9% to $182.50 premarket
BDX now expects its 2025 adjusted profit per share between $14.30 and $14.45, compared with its prior range of $14.06 to $14.34
It reaffirms its annual revenue to be between $21.8 billion and $21.9 billion, compared with analysts' estimates of $21.83 billion, according to data compiled by LSEG
Company reported a profit of $3.68 per share on an adjusted basis for the quarter ended June 30, beating estimates of $3.40 per share
Quarterly sales for the company came in at $5.51 billion, above estimates of $5.49 billion
"We think today's update should be enough to satisfy investor expectations," says brokerage J.P.Morgan
Up to last close, stock down 24% YTD